Speakers

Norzehan Abdul-Manan, Ph.D., Structural Biology, Vertex Pharmaceuticals Inc.
Samantha Allen, Ph.D., Senior Research Biochemist, Structural Biology, Merck & Co.
Yi Ao, Ph.D., Scientist II, Formulation Development, MedImmune, Inc.
Sathy Balu-Iyer, Ph.D., Associate Professor, Pharmaceutical Sciences, SUNY - University at Buffalo
Nuno Bandeira, Ph.D., Executive Director, University of California, San Diego
Frank Bernhard, Ph.D., Lab Leader, Institute of Biophysical Chemistry, Goethe-University Frankfurt
James U. Bowie, Ph.D., Professor, University of California, Los Angeles
Patrick Boylan, Senior Scientist, GlaxoSmithKline Biologicals
Kathlynn C. Brown, Assistant Professor, University of Texas Southwestern Medical School
Konrad Bussow, Ph.D., Project leader, Structural Biology, Helmholtz Centre for Infection Research
Jill Carlton, Associate Director, Centocor R&D
Stephen P. Chambers, Ph.D., Vice President, Protein Production, AbPro
Thomas Chappell, Ph.D., Founder and Principal Scientist, BioGrammatics
Deb K. Chatterjee, Ph.D., Associate Director and Sr. Principal Scientist, Protein Expression Laboratory,      SAIC-Frederick, Inc.
Quanmin Chen, Ph.D., Scientist, Process Biochemistry & Formulation Sciences, MedImmune, Inc.
Wei Chen, Ph.D., Senior Research Scientist, Pharmaceutical Sciences Research and Development, Eli Lilly and Company
Naresh Chennamsetty, Ph.D., Post-Doctoral Associate, Chemical Engineering, Massachusetts Institute of Technology
Hung-Wei Chih, Ph.D., Early Stage Pharmaceutical Development, Genentech
Jeannick Cizeau, Ph.D., Director, Research, Viventia Biotechnologies
Theodore Clark, Ph.D., Associate Professor, Microbiology & Immunology, Cornell University
Matthew A. Coleman, Ph.D., Senior Scientist, Biosciences, Lawrence Livermore National Laboratory
David Craik, Professor, The University of Queensland
William A. Cramer, Ph.D., Distinguished Professor, Biological Sciences, Purdue University
Dan L. Crimmins, Ph.D., Senior Scientist, Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine
Jeffrey S. Culp, Ph.D., Associate Research Fellow, Primary Pharmacology Group, Pfizer Global R & D
Lawrence DeLucas, Ph.D., Center for Biophysical Sciences and Engineering, University of Alabama at Birmingham
Elsie DiBella, Ph.D., Assistant Director, Purification Process Development, Shire Human Genetic Therapies
Dimiter Dimitrov, Ph.D., Senior Investigator, Protein Interaction Group, National Cancer Institute, National Institutes of Health (NIH)
Steven F. Dowdy, Professor, University of California-San Diego
Boro Dropulic, President & CSO, Lentigen Corp.
Robert L. Dufield, Principal Scientist, Analytical R&D: Protein Impurity Characterization, Pfizer Inc.
Jennifer Dumont, Ph.D., Senior Director, Research & Development, Syntonix Pharmaceuticals, a subsidiary of Biogen Idec
Alan L. Epstein, M.D., Ph.D., Professor, Pathology, Keck School of Medicine, University of Southern California
Dominic Esposito, Protein Expression Lab, SAIC Frederick Inc.
Joachim Feldwisch, Ph.D., Project Manager, Affibody AB
Ewa Folta-Stogniew, Ph.D., Director of Biophysics Resource, Molecular Biophysics and Biochemistry, Yale University, Keck Lab
Kurt Forrer, Ph.D., Analytical R&D, Novartis Pharma AG
Andrew Fosberry, Ph.D., Research Investigator, Biological Reagents & Assay Development, GlaxoSmithKline
Wolfgang Fraunhofer, Ph.D., Group Leader, Associate Research Fellow, Global Pharmaceutical and Analytical Development, Abbott Bioresearch Center
Eric Furfine, Ph.D., Senior Vice President, Research & Preclinical Development, Adnexus – a Bristol Myers Squibb R&D Co.
Shishir Gadam, Ph.D., Director, Manufacturing Science and Technical Services, Vacaville Operations, Genentech
Nathan Geething, Ph.D., Scientist, Process Development, Amunix, Inc.
Tariq Ghayur, Ph.D., Senior Principal Scientist & Research Fellow, Biologics, Abbott Bioresearch Center Inc.
Jan-Willem de Gier, Ph.D., Associate Professor & Group Leader, Center for Biomembrane Research, Stockholm University; Chief Technical Officer, Xbrane bioscience AB
William Gillette, Ph.D., Senior Scientist, Protein Expression Lab, SAIC- Frederick, NCI
David M. Goldenberg, M.D., Center for Molecular Medicine and Immunology, Garden State Cancer Center
Adam Goldstein, Ph.D., Senior Manager, Clinical Operations, Genentech
James Graziano, Ph.D., Chief Operating Officer, Protein Sciences, Fabrus LLC
Vincent de Groot, Ph.D., CLP, Chief Executive Officer, Syntarga B.V.
Franz Gruswitz, Ph.D., Department of Biochemistry & Biophysics, UCSF
Vincent Guerlavais,  Principal Scientist, Aileron Therapeutics, Inc
Erika Gustafsson, Ph.D., Scientist &Project Manager, Alligator Bioscience AB
Nick Guziewicz, Ph.D., Principal Research Associate, BioFormulations Development, Genzyme Corporation
Michael Hanson, Ph.D., Scientist, Receptos, Inc.
Lisa Hardwick, Research Scientist I, Baxter BioPharma Solutions
Hanjo Hennemann, CEO & CSO, Nexigen GmbH
David P. Humphreys, Ph.D., Senior Group Leader, Antibodies, UCB Celltech
Ian Hunt, Ph.D., Protein Structure Unit, Centre for Proteomic Chemistry, Novartis Institutes for      BioMedical Research
Masa Iwakura, Ph.D., Principal Researcher, Institute for Biological Resources and Functions, National Institute of Advanced Industrial Science and Technology (AIST)
Robert Johnson, Ph.D., Principal Scientist, Global Biologics, Pfizer Global R&D
Syd Johnson, Ph.D., Vice President, Antibody Engineering, MacroGenics, Inc.
H. Ronald Kaback, Ph.D., Professor, Structural Studies & Biophysics, Physiology, University of California, Los Angeles
Peter Kaiser, Ph.D., Associate Professor, Department of Biological Chemistry, University of California, Irvine
Devendra (Davy) S. Kalonia, Ph.D., Professor of Pharmaceutics, University of Connecticut
Sonoko Kanai, Ph.D., Scientist, Pharmaceutical and Analytical R&D, F. Hoffmann-La Roche AG
John Karanicolas, Ph.D., Assistant Professor, Department of Molecular Biosciences, and Center for Bioinformatics, University of Kansas
Malcolm Kennard, Ph.D., Consultant, Kennard Associates
Robert J. Kreitman, M.D., Principal Investigator, Clinical Immunotherapy Section, National Cancer Institute (NCI), National Institutes of Health (NIH) 
Judy E. Kim, Ph.D., Assistant Professor, Department of Chemistry and Biochemistry,University of California, San Diego
David King, Ph.D., Vice President, Research, AnaptysBio Inc.
Carol F. Kirchhoff, Ph.D., Senior Principal Scientist, Pharmaceutical R&D, Global Biologics, Pfizer, Inc.
Mark Knuth, Ph.D., Scripps Institute
Venkat R. Koganti, Ph.D., Senior Scientist, Parenteral Center of Emphasis, Pfizer, Inc.
Parag Kolhe, Ph.D., Principal Scientist, Global Research and Development, Global Biologics, Pfizer, Inc.
Christopher Koth, Ph.D., Scientist, Structural Biology, Genentech, Inc.
Tsumoto Kouhei, Ph.D., Associate Professor, Division of Frontier Biosciences, University of Tokyo
Alla Korepanova, Ph.D., Senior Researcher, Department of Structural Biology, GPRD Abbott Laboratories
Rachel H. Kravitz, Ph.D., Director of Research, NeoClone Biotechnology
W. Antoni Kudlicki, Cloning & Protein Expression R&D, Life Technologies
John Kulman, Ph.D., Assistant Member, Puget Sound Blood Center
Yune Kunes, Associate Director, Abbott Research Bioresearch Center
Bill Lambert, Senior Vice President, Pacira Pharmaceuticals, Inc.
Thomas M. Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
Mark Levenstein, Ph.D., Scientific Director, Biochemistry, CDI Bioscience
Geoffrey Lin-Cereghino, Ph.D., Assoc. Professor, Chemistry, College of the Pacific-Stockton
Chao-Min Liu, Ph.D., Distinguished Research Leader, F. Hoffmann La Roche Inc.
Joseph A. Loo, Ph.D., Prof. , Dept of Chemistry and Biochemistry,  UCLA
Lawrence G. Lum, M.D., D.Sc., Professor of Medicine; Professor of Immunology and Microbiology; Scientific Director of Immunotherapy and BMT; Barbara Ann Karmanos Cancer Institute
Benjamin J. McFarland, Ph.D., Seattle Pacific University
Helen Mao, Ph.D., Chief Scientific Officer, Fabrus LLC
Mulugeta Mamo, Ph.D., Dept of Structural Biology, Abbott Laboratories
Russell Martin, Research Associate II, Research & Development, Aridis Pharmaceuticals
Stephen Mayfield, Ph.D., Department of Cell Biology and The Skaggs Institute for Chemical Biology, The Scripps Research Institute
Larry Miercke, Ph.D., Specialist, Biochemistry, UCSF
David Mills, Professor, University of California Davis
Daniel L. Minor, Jr., Associate Prof., California Institute for Quantitative Biosciences, UCSF
Jamie Moore, Ph.D., Scientist and Group Leader, Early Stage Pharmaceutical Development, Genentech, Inc.
Christopher Murray, Ph.D., Senior Director, Research, Sutro Biopharma
Isabelle Mus-Veteau, Ph.D., Senior Scientist and Group Leader, Laboratoire de Physiologie Cellulaire et Moléculaire, LBPSI, Université de Nice – Sophia Antipolis, CNRS
Vladimir Muzykantov, Ph.D., Associate Professor, Pharmacology, University of Pennsylvania
Michael Naso, Ph.D., Senior Research Scientist, Discovery Research, Centocor
Phuong Nguyen, Ph.D., Scientist, Parenteral Formulation Sciences, Millennium Pharmaceuticals, Inc.
Stephan Noll, Ph.D., Senior Scientist, Gene Bridges GmbH
Peter Nollert, Ph.D., Director, Emerald Biosystems
Satoshi Ohtake, Ph.D., Scientist, Research and Development, Aridis Pharmaceuticals
Denise M. O'Hara, Ph.D., Associate Director, Bioanalytical R&D, Drug Safety & Metabolism, Wyeth Research 
Deborah O’Neil, Founder & CEO, NovaBiotics Ltd.
C. Nick Pace, Ph.D., Professor, Medical Biochemistry and Genetics and of Biochemistry and Biophysics, Texas A&M
Palani Palaniappan, Ph.D., Senior Director, Analytical & Formulation Sciences, Millennium Pharmaceuticals, Inc. a Takeda Oncology Company
William M. Pardridge, M.D., Professor, Medical Endocrinology, University of California, Los Angeles, and Chief Scientific Officer, ArmaGen Technologies, Inc.
Missag Parseghian, Ph.D., Senior Director, R&D, Peregrine Pharmaceuticals, Inc.
B. Daniel Pierce, Biology, Johns Hopkins University
Michael J. Pikal, Ph.D., Pfizer Distinguished Endowed Chair in Pharmaceutical Technology & Professor of Pharmaceutics, University of Connecticut
Feng Qian, Ph.D., Senior Research Investigator, Portfolio Enabling Technology, Biopharmaceutics R&D, Bristol-Myers Squibb, Co.
Noelene Quinsey, Ph.D., Manager, Biochemistry and Molecular Biology, Monash University
John Quinn, Ph.D., Chief Scientific Officer, IcX Technologies
Stephen Quirk, Director, Enabling Technologies, Kimberly Clark
Gopalan Raghunathan, Ph.D., Research Fellow, Antibody Design, Centocor Discovery Research
James Rebbeor, PhD, Manager, Process Sciences, Process Development & Technology, Talecris Biotherapeutics
Lynne Regan, Ph.D., Professor, Molecular Biophysics & Biochemistry and Chemistry, Yale University
Christopher A. Rhodes, Ph.D., Executive Director, Pharmaceutical Sciences, Amylin Pharmaceuticals, Inc.
Anne Robinson, Ph.D., Professor, Chemical Engineering, University of Delaware
Michael Ruberto, Ph.D., President, Material Needs Consulting
Israel (Rudi) Rubinstein, M.D., Professor of Medicine and Biopharmaceutical Sciences; Director, Respiratory Therapy, Jesse Brown VA Medical Center, University of Illinois at Chicago
Lukas K Tamm, Ph.D., Professor, Molecular Physiology & Biological Physics, The University of Virginia
Matthías Thórólfsson, Ph.D., Research Scientist, Protein Structure and Biophysics, Novo Nordisk A/S
Elizabeth Topp, Ph.D., Dane O. Kildsig Professor and Department Head, Industrial Pharmacy and Pharmaceutics, Purdue University
Erica Ollman Saphire, Ph.D., Asst. Professor, Dept. of Immunology & Microbial Science, Scripps Institute
Heiko Schiffter, Ph.D., Brasenose Research Fellow in Biomedical Engineering, Engineering Science, University of Oxford
Roland Schmidt, Ph.D., Principal Pharmaceutical Scientist, Manufacturing Science, Abbott Laboratories
Stefan Schulte, Ph.D., Head Pre-Clinical R&D, CSL Behring GmbH
Giuliano Sciara, Ph.D., Post Doctoral Researcher, Columbia University
Zahra Shahrokh, Ph.D., Senior Director, Pharmaceutical & Analytical Development, Shire Human Genetic Therapies
Evgenyi Shalaev, Ph.D., Associate Research Fellow, Parenteral Center of Emphasis, Pfizer, Inc.
Noam Shani, Ph.D., Chief Executive Officer, KAHR Medical Ltd.
Wei-Chiang Shen, Ph.D., John A. Biles Professor, Pharmacology & Pharmaceutical Sciences, School of Pharmacy, University of Southern California
Stefan Schmidt, Ph.D., Vice President, Technology, ERA Biotech
Li Shi, Ph.D., Senior Director, Technology Development, Genzyme, Inc.
Steven J. Shire, Ph.D., Staff Scientist and Group Leader, Process R&D, Genentech, Inc.
Manmohan Singh, Ph.D., Head, U.S. Vaccine Delivery and Formulation Research, Novartis Vaccines
Arjan Snijder, Ph.D., Associate Principle Scientist, Cell Proteins and Structural Sciences, AstraZeneca
Herman E. Snyder, Ph.D., PARSEC Solutions LLC; former Senior Research Fellow, Nektar Therapeutics
Peter Sonderman, Ph.D., Chief Scientific Officer, SuppreMol GmbH
Robert Speight, Ph.D., Operations Director, Ingenza Ltd.
Indresh Srivastava, Ph.D., Associate Director, Vaccines Research, Protein Biochemistry, Novartis Vaccines & Diagnostics Inc.
Philippe Stas, Ph.D., Chief Executive Officer, AlgoNomics NV
Patrick S. Stayton, Professor, Washington University
Jason Steel, Research Scientist, Arizona State University
Lawrence Steinman, M.D., Professor, Neurology, Stanford University
Hongsheng Su, Ph.D., Director, Process Development, Osprey Pharmaceuticals Limited
Nanda Subbarao, Ph.D., Senior Consultant, Analytical-CMC, Biologics Consulting Group
Ronald P. Taylor, Ph.D., Professor, Biochemistry and Molecular Genetics, The University of Virginia School of Medicine
Vassia Tegoulia, Ph.D., Scientist, Regulatory CMC, Genentech, Inc.
Jörg Thömmes, Ph.D., Director, Purification Development, Biogen Idec
Sanjay Tiwari, Senior Scientific Manager, Research and Development, Biocon Ltd
Emiliano Toso, Head of Molecular Biology Lab, RBM Merck Serono
Chris Ullman, CSO, Isogenica Ltd.
Sven Valla, Professor, Norwegian University
Eric von Hofe, President, R&D, Antigen Express
Wenyan Wang, Ph.D., Structural Chemistry, Schering-Plough Research Institute
William W. Ward, Ph.D., Associate Professor, Director, CREBB, Biochemistry Cook College, Rutgers University
Paul M. Watt, CSO & VP, Phylogica Ltd.
David S. Waugh, Ph.D., Chief, Protein Engineering Section, Macromolecular Crystallography Laboratory, National Cancer Institute, National Institutes of Health (NIH)
David B Weiner, Professor, University of Pennsylvania
An-Suei Yang, Ph.D., Deputy Director & Associated Research Fellow, Genomics Research Center, Academia Sinica, Taiwan 
Jianxin Ye, Ph.D., Research Staff Scientist, Merck Research Labs
Alexei Yeliseev, Ph.D., Staff Scientist & Head, GPCR Expression and Analysis Group, National Institute on Alcoholism and Alcohol Abuse, National Institutes of Health (NIH)
Jennifer W. Yohrling, Ph.D., Associate Director, PK Assay Development and Validation, Clinical Pharmacology Sciences, Centocor R&D
Travis Young, Peter G. Schultz Lab, The Scripps Institute
Chenming (Mike) Zhang, Ph.D., Associate Professor, Biological Systems Engineering, Virginia Polytechnic Institute & State University
Jianbing Zhang, Ph.D., Institute for Biological Sciences, NRC Canada
Jifeng Zhang, Ph.D., Principal Scientist, Department of Analytical and Formulation Sciences, Amgen, Inc.
Qinghai Zhang, Ph.D., Asst. Professor, Molecular Biology, Scripps Institute
Yonghong Zhao, Ph.D., Research Scientist, MDT, Centocor R&D Inc.
Andrew Zydney, Ph.D., Head, Chemical Engineering, College of Engineering, Pennsylvania State University